Search for: [Abstract = "n of the treatment and rising in subsequent months. The mean haemoglobin values returned to normal, low limit 6 month after beginning of the therapy. Third grade toxicity in respect to haemoglobin was observed in 7 patients \(23,3%\), 4 grade toxicity in 1 person. Red blood cell concentrate transfusion was necessary in 10 patients \(33,3%\). Low haemoglobin levels lasted for 2 weeks in all but 1 patient, in whom it persisted for 3 weeks.RIT did not influence creatinine and AlAT levels. In most of the patients with NET stabilization or partial remission was observed. Due to the isotope labelled somatostatin analoque treatment expected life prolongation and shrinkage of the non\-operative tumour was possible in patients with disseminated disease. This treatment caused complete relief or tone down clinical symptoms accompanying disease in all patients with stabilization of partial remission of the neoplasmatic process, improving quality of life. In patients who received full planned treatment partial remission was observed in 44%, stabilization of the disease in 30% and progression of the disease in 26 % of patients. The mean time to progression was 17,7 month. 7 patients died before the completion of the planned treatment. After the completion of the planned treatment only 2 patients in whom the progression of the disease was found died. In the whole group, regardless full, or not c"]

Number of results: 1